Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short Course Rifampin vs INH for LTBI in Jail
NCT00128206Phase 3Completed
- Sponsor
- University of California, San Francisco
- Start
- Nov 2004
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rifampicin in Tuberculosis (TB), sponsored by University of California, San Francisco. Started Nov 2004; status: completed.
02
Drugs
rifampicin
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT00128206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00128206.